Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-28 5:40 pm Sale |
2025-01-27 | 13D | Acutus Medical, Inc. AFIB |
James E. Flynn | 5,492,725 9.100% |
-4,213,132 (-43.41%) |
Filing History |
| 2025-01-23 9:16 pm Unchanged |
2025-01-21 | 13D | Acutus Medical, Inc. AFIB |
James E. Flynn | 9,705,857 9.100% |
0 (Unchanged) |
Filing History |
| 2024-12-26 8:55 pm Unchanged |
2024-12-22 | 13D | Singular Genomics Systems, Inc. OMIC |
James E. Flynn | 249,495 6.620% |
0 (Unchanged) |
Filing History |
| 2024-12-16 9:52 pm Purchase |
2024-12-12 | 13D | Acutus Medical, Inc. AFIB |
James E. Flynn | 9,705,857 9.100% |
28,000 (+0.29%) |
Filing History |
| 2024-11-15 6:03 pm Purchase |
2024-11-08 | 13G | Indivior PLC INDV |
James E. Flynn | 7,363,210 5.800% |
7,363,210 (New Position) |
Filing History |
| 2024-11-14 09:56 am Purchase |
2024-09-30 | 13G | DocGo Inc. DCGO |
James E. Flynn | 9,066,138 8.880% |
3,745,999 (+70.41%) |
Filing History |
| 2024-11-14 09:55 am Sale |
2024-09-30 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
James E. Flynn | 6,229,634 5.220% |
-2,659,267 (-29.92%) |
Filing History |
| 2024-11-14 09:03 am Sale |
2024-09-30 | 13G | AdaptHealth Corp. AHCO |
James E. Flynn | 23,758,393 7.220% |
-3,896,530 (-14.09%) |
Filing History |
| 2024-11-14 09:02 am Sale |
2024-09-30 | 13G | Verastem, Inc. VSTM |
James E. Flynn | 0 0.000% |
-1,538,461 (Position Closed) |
Filing History |
| 2024-11-14 09:01 am Sale |
2024-09-30 | 13G | Nuo Therapeutics, Inc. AURX |
James E. Flynn | 1,026,324 2.200% |
-1,156,840 (-52.99%) |
Filing History |
| 2024-11-14 09:00 am Sale |
2024-09-30 | 13G | HilleVax, Inc. HLVX |
James E. Flynn | 1,882,654 3.780% |
-2,121,577 (-52.98%) |
Filing History |
| 2024-11-14 08:59 am Sale |
2024-09-30 | 13G | Edgewise Therapeutics, Inc. EWTX |
James E. Flynn | 1,781,006 1.900% |
-2,697,586 (-60.23%) |
Filing History |
| 2024-11-14 08:57 am Purchase |
2024-09-30 | 13G | Ventyx Biosciences, Inc. VTYX |
James E. Flynn | 6,715,501 9.500% |
3,173,501 (+89.60%) |
Filing History |
| 2024-11-14 08:56 am Sale |
2024-09-30 | 13G | Solid Biosciences Inc. SLDB |
James E. Flynn | 0 0.000% |
-2,260,398 (Position Closed) |
Filing History |
| 2024-11-14 08:55 am Sale |
2024-09-30 | 13G | Nkarta, Inc. NKTX |
James E. Flynn | 2,155,000 3.050% |
-1,245,000 (-36.62%) |
Filing History |
| 2024-11-14 08:54 am Purchase |
2024-09-30 | 13G | Merus N.V. MRUS |
James E. Flynn | 3,408,539 4.980% |
388,638 (+12.87%) |
Filing History |
| 2024-11-14 08:54 am Purchase |
2024-09-30 | 13G | MALLINCKRODT PLC SHS MNKTQ |
James E. Flynn | 1,460,233 7.410% |
179,000 (+13.97%) |
Filing History |
| 2024-11-14 08:53 am Unchanged |
2024-09-30 | 13G | Windtree Therapeutics, Inc. WINT |
James E. Flynn | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-11-12 6:58 pm Purchase |
2024-11-06 | 13G | Oscar Health, Inc. OSCR |
James E. Flynn | 11,835,000 5.590% |
588,180 (+5.23%) |
Filing History |
| 2024-11-08 4:49 pm Purchase |
2024-11-01 | 13G | Lomond Therapeutics Holdings, Inc. | James E. Flynn | 2,692,625 9.900% |
2,692,625 (New Position) |
Filing History |